» Authors » Philip E Schaner

Philip E Schaner

Explore the profile of Philip E Schaner including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 369
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Petryakov S, Kmiec M, Ubert C, Kassey V, Schaner P, Kuppusamy P
J Magn Reson . 2024 May; 362:107690. PMID: 38692250
This research report describes a novel surface dielectric resonator (SDR) with a flexible connector for in vivo electron paramagnetic resonance (EPR) spectroscopy. Contrary to the conventional cavity or surface loop-gap...
2.
Duval K, Aulwes E, Zhang R, Rahman M, Ashraf M, Sloop A, et al.
Radiat Res . 2023 Aug; 200(3):223-231. PMID: 37590482
Recent studies suggest ultra-high dose rate radiation treatment (UHDR-RT) reduces normal tissue damage compared to conventional radiation treatment (CONV-RT) at the same dose. In this study, we compared first, the...
3.
Schaner P, Chandra R
JAMA Oncol . 2022 Jan; 8(3):372-373. PMID: 35050319
No abstract available.
4.
Rahman M, Ashraf M, Gladstone D, Bruza P, Jarvis L, Schaner P, et al.
Int J Radiat Oncol Biol Phys . 2021 Nov; 112(4):1023-1032. PMID: 34762969
Purpose: To present a Monte Carlo (MC) beam model and its implementation in a clinical treatment planning system (TPS, Varian Eclipse) for a modified ultrahigh dose-rate electron FLASH radiation therapy...
5.
Chen E, Tse D, Hou H, Schreiber W, Schaner P, Kmiec M, et al.
Appl Magn Reson . 2021 Nov; 52(10):1321-1342. PMID: 34744319
Objectives: (1) Summarize revisions made to the implantable resonator (IR) design and results of testing to characterize biocompatibility;(2) Demonstrate safety of implantation and feasibility of deep tissue oxygenation measurement using...
6.
Kmiec M, Hebert K, Tse D, Hodge S, Williams B, Schaner P, et al.
Magn Reson Med . 2021 Oct; 87(3):1621-1637. PMID: 34719047
Purpose: Electron paramagnetic resonance oximetry using the OxyChip as an implantable oxygen sensor can directly and repeatedly measure tissue oxygen levels. A phase I, first-in-human clinical study has established the...
7.
Schaner P, Williams B, Chen E, Pettus J, Schreiber W, Kmiec M, et al.
Front Oncol . 2021 Oct; 11:743256. PMID: 34660306
Objective: The overall objective of this clinical study was to validate an implantable oxygen sensor, called the 'OxyChip', as a clinically feasible technology that would allow individualized tumor-oxygen assessments in...
8.
Skinner H, Hu C, Tsakiridis T, Santana-Davila R, Lu B, Erasmus J, et al.
JAMA Oncol . 2021 Jul; 7(9):1324-1332. PMID: 34323922
Importance: Non-small cell lung cancer (NSCLC) has relatively poor outcomes. Metformin has significant data supporting its use as an antineoplastic agent. Objective: To compare chemoradiation alone vs chemoradiation and metformin...
9.
Swartz H, Flood A, Williams B, Pogue B, Schaner P, Vaupel P
Adv Exp Med Biol . 2021 May; 1269:301-308. PMID: 33966234
Clinical measurements of O in tissues will inevitably provide data that are at best aggregated and will not reflect the inherent heterogeneity of O in tissues over space and time....
10.
Schaner P, Tran L, Zaki B, Swartz H, Demidenko E, Williams B, et al.
Sci Rep . 2021 Feb; 11(1):4422. PMID: 33627688
During a first-in-humans clinical trial investigating electron paramagnetic resonance tumor oximetry, a patient injected with the particulate oxygen sensor Printex ink was found to have unexpected fluorodeoxyglucose (FDG) uptake in...